Literature DB >> 23743736

Bilateral urinary calculi with discordant stone composition.

Adam O Kadlec1, Zachary C Fridirici, Alex M Acosta-Miranda, Thomas H Will, Kyoko Sakamoto, Thomas M T Turk.   

Abstract

OBJECTIVES: To describe a cohort of bilateral stone formers with significantly different compositions between renal units.
METHODS: Patients treated for bilateral nephrolithiasis over a 4-year period (2007-2010) were identified. Stones were categorized by dominant (≥50%) mineralogical component. Patients with significant compositional differences between renal units (discordant stone formers) were compared to patients with a similar stone type in each kidney.
RESULTS: Fifteen of the 59 bilateral stone formers (25.4%) were discordant stone formers with significant differences in stone composition between renal units. Forty-four of the 59 patients (74.6%) had the same stone composition on each side. Thirty percent of discordant stones had calcium phosphate as the dominant stone component. Discordant stone formers were younger, had better renal function, and tended to have a larger stone burden (p < 0.05).
CONCLUSIONS: A significant minority of bilateral stone formers form a different type of stone in each kidney. Local or micro-environmental etiologies may explain this phenomenon and may also account for failure of preventive therapy in some patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23743736     DOI: 10.1007/s00345-013-1113-4

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  15 in total

1.  Do vesical and voided urine have identical compositions?

Authors:  Ahmed Shafik; Olfat El Sibai; Ali A Shafik; Ismail Ahmed
Journal:  Scand J Urol Nephrol       Date:  2004

2.  Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis.

Authors:  J Kourambas; P Aslan; C L Teh; B J Mathias; G M Preminger
Journal:  J Endourol       Date:  2001-03       Impact factor: 2.942

Review 3.  Stone composition: where do we stand?

Authors:  A Saita; A Bonaccorsi; M Motta
Journal:  Urol Int       Date:  2007       Impact factor: 2.089

Review 4.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

5.  Essential arterial hypertension and stone disease.

Authors:  L Borghi; T Meschi; A Guerra; A Briganti; T Schianchi; F Allegri; A Novarini
Journal:  Kidney Int       Date:  1999-06       Impact factor: 10.612

6.  Changes in the urine composition during its passage through the ureter. A concept of urothelial function.

Authors:  Ahmed Shafik; Ismail Shafik; Olfat El Sibai; Ali A Shafik
Journal:  Urol Res       Date:  2005-11-13

Review 7.  Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis.

Authors:  A Evan; J Lingeman; F L Coe; E Worcester
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

8.  Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy.

Authors:  Andrew P Evan; James E Lingeman; Fredric L Coe; Sharon B Bledsoe; Andre J Sommer; James C Williams; Amy E Krambeck; Elaine M Worcester
Journal:  Kidney Int       Date:  2009-08-26       Impact factor: 10.612

Review 9.  Obesity and urolithiasis.

Authors:  John R Asplin
Journal:  Adv Chronic Kidney Dis       Date:  2009-01       Impact factor: 3.620

Review 10.  Prevention of stone disease.

Authors:  M Porena; P Guiggi; C Micheli
Journal:  Urol Int       Date:  2007       Impact factor: 2.089

View more
  2 in total

1.  Are stone analysis results different with repeated sampling?

Authors:  Terence T N Lee; Mohamed A Elkoushy; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

2.  Variability in stone composition and metabolic correlation between kidneys in patients with bilateral nephrolithiasis.

Authors:  Marcelino E Rivera; Charles U Nottingham; Michael S Borofsky; Suzanne M Kissel; Viraj Maniar; Casey A Dauw; Nadya E York; Amy E Krambeck; James E Lingeman
Journal:  Int Urol Nephrol       Date:  2019-12-20       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.